Health disparities and direct-to-consumer advertising of pharmaceutical products

Advances in Health Economics and Health Services Research

Volumn 19, Issue , 2008, Pages 71-94

  Avery, Rosemary J ^a   Kenkel, Donald ^a   Lillard, Dean R ^a   Mathios, Alan ^a   Wang, Hua ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

ADOLESCENT; ADULT; ADVERTIZING; AGED; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; DRUG INDUSTRY; ETHNIC GROUP; FEMALE; HEALTH DISPARITY; HUMAN; MALE; MIDDLE AGED; REGRESSION ANALYSIS; REVIEW; SOCIOECONOMICS; STATISTICS; TELEVISION; UNITED STATES;

ADOLESCENT; ADULT; ADVERTISING AS TOPIC; AGED; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DRUG INDUSTRY; ETHNIC GROUPS; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MALE; MIDDLE AGED; PRESCRIPTION DRUGS; REGRESSION ANALYSIS; SOCIOECONOMIC FACTORS; TELEVISION; UNITED STATES; YOUNG ADULT;

EID: 53749089958     PISSN: 07312199     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0731-2199(08)19004-5     Document Type: Review

References (43)

1. Agency for Healthcare Research and Quality. National healthcare disparities report (2006, December), US Department of Health and Human Services, Rockville, MD
2. Angell M. The truth about drug companies: How they deceive us and what to do about it (2005), Random House Trade Paperbacks, New York
3. Arias E. United States life tables, 2002. National Vital Statistics Reports 53 6 (2004) 1-6
4. Arrow K.J. Uncertainty and the welfare economics of medical care. American Economic Review 53 (1963) 941-973
5. Avery R.J., Kenkel D.S., Lillard D., and Mathios A.D. Regulating advertisements: The case of smoking cessation products. Journal of Regulatory Economics 31 2 (2007) 185-208
6. Avery R.J., Kenkel D.S., Lillard D., and Mathios A.D. Private profits and public health: Does advertising smoking cessation products encourage smokers to quit?. Journal of Political Economy 115 3 (2007) 447-481
7. In: Baciu A., Stratton K., and Burke S.P. (Eds). The future of drug safety: Promoting and protecting the health of the public (2006), Committee on the Assessment of the US Drug Safety System, Institute of Medicine
8. Berndt E.R., Bui L., Reiley D.R., Glen L., and Urban G.L. Information, marketing, and pricing in the US antiulcer drug market. American Economic Review Papers and Proceedings 85 2 (1995) 100-105
9. Cutler, D. M., Landrum, M. B., & Stewart, K. A. (2006, February). How do the better educated do it? Socioeconomic status and the ability to cope with underlying impairment. NBER Working Paper no. 10240.
10. Cutler, D. M., & Lleras-Muney, A. (2006, June). Education and health: Evaluating theories and evidence. NBER Working Paper no. 12352.
11. Cutrona S.L., Woolhander S., Lasser K.E., Bor D.H., McCormick D., and Himmelstein D.U. Characteristics of recipients of free prescription drug samples: A nationally representative analysis. American Journal of Public Health 98 2 (2008)
12. Deaton A. Policy implications of the gradient of health and wealth. Health Affairs 21 2 (2002) 13-30
13. Donohue J.M., Cevasco M., and Rosenthal M.B. A decade of direct-to-consumer advertising of prescription drugs. New England Journal of Medicine 357 (2007) 673-681
14. Frank, R., Berndt, E. R., Donohue, J., Epstein, A., & Rosenthal, M. (2002, February). Trends in direct-to-consumer advertising of prescription drugs. Menlo Park, California: The Henry J. Kaiser Family Foundation.
15. Glied, S., & Lleras-Muney, A. (2003, May). Health inequality, education, and medical innovation. NBER Working Paper no. 9738.
16. Goldman, D., & Lakdawalla, D. (2001, June). Understanding health disparities across education groups. NBER Working Paper no. 8328.
17. Grossman M. Education and nonmarket outcomes. In: Hanushek E., and Welch F. (Eds). Handbook of the economics of education (2006), North-Holland, an imprint of Elsevier Science, Amsterdam
18. Ippolito P.M., and Mathios A.D. Information, advertising and health choices: A study of the cereal market. RAND Journal of Economics 21 3 (1990) 459-480
19. Ippolito P.M., and Mathios A.D. Information and advertising: The case of fat consumption in the United States. American Economic Review Papers & Proceedings 85 2 (1995)
20. Kaphingst K.A., and DeJong W. The educational potential of direct-to-consumer prescription drug advertising. Health Affairs 23 4 (2004) 143-150
21. Kenkel D.S. Health behavior, health knowledge, and schooling. Journal of Political Economy 99 2 (1991) 287-305
22. Keppel K., Bilhelmer L., and Gurley L. Improving population health and reducing healthcare disparities. Health Affairs 26 5 (2007) 1281-1292
23. Ling D.C., Berndt E.R., and Kyle M.K. Deregulating direct-to-consumer marketing of prescription drugs: Effects on prescription and over-the-counter product sales. Journal of Law and Economics XL (2002) 691-723
24. Link B.G., and Phelan J. Social conditions as fundamental causes of disease. Journal of Health and Social Behavior Extra Issue (1995) 80-94
25. Lleras-Muney, A., & Lichtenberg, F. R. (2002, September). The effect of education on medical technology adoption: Are the more educated more likely to use new drugs? NBER Working Paper no. 9185.
26. Manning, R. (2006, October 20). Direct-to-consumer advertising. Presentation at Federal Trade Commission Bureau of Economics Roundtable. Pfizer, Inc.
27. Marmot M.G., Davey Smith G., Stansfeld S., Patel C., North F., Head J., White I., Brunner E., and Feeny A. Health inequalities among British civil servants: The Whitehall II study. Lancet (1991) 1387-1393
28. McGuire T.G. Physician agency. In: Culyer A.J., and Newhouse J.P. (Eds). Handbook of health economics 1A (2000), North-Holland, Amserdam 461-536
29. Meara, E. (2001, April). Why is health related to socioeconomic status? The case of pregnancy and low birth weight. NBER Working Paper no. 8231.
30. Mechanic D. Disadvantage, inequality, and social policy. Health Affairs 21 2 (2002) 48-59
31. Morris A.W., Gadson S.L., and Burroughs V. For the good of the patient, survey of the physicians of the National Medical Association regarding perceptions of DTC advertising, Part, 1.1, 2006. Journal of the National Medical Association 99 3 (2007) 287-293
32. Nelson K., Norris K., and Mangione C.M. Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity. Archives on Internal Medicine 162 (2002) 929-935
33. Rogot E., Sorlie P.D., Johnson N.L., and Schmit C. A mortality study of 1.3 million persons by demographic, social, and economic factors: 1979-1985 follow-up (1992), National Institutes of Health, Bethesda
34. Scott-Morton F. Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry. International Journal of Industrial Organization 18 7 (2000) 1085-1104
35. Smith J.P. Health bodies and thick wallet: The dual relation between health and economic status. Journal of Economic Perspectives 13 2 (1999) 145-166
36. Steadman, J. (2005, Summer). TV audience special study: African-American audience. Nielsen Media Research.
37. US Department of Health and Human Services. Healthy People 2010: Understanding and improving Health. 2nd (2000, November), US Government Printing Office, Washington, DC
38. Vogt, D. U. (2005, March 25). Direct-to-consumer advertising of prescription drugs. Congressional Research Service: The Library of Congress.
39. Wang J., Zuckerman I.H., Miller N.A., Shaya F.T., Noel J.M., and Mullins C.D. Utilizing new prescription drugs: Disparities among non-Hispanic whites, non-Hispanic Blacks, and Hispanic whites. Health Services Research 42 4 (2007) 1499-1519
40. Weissman, J. S., Blumenthal, D., Silk, A. J., Zapert, K., Newman, M., & Leitman, R. (2003). Consumers' reports on the health effects of direct-to-consumer drug advertising. Health Affairs. Web Exclusive W3-82-W3-95.
41. Wilkes M.S., Bell R.A., and Kravitz R.L. Direct-to-consumer prescription drug advertising: Trends, impact, and implications. Health Affairs 19 2 (2000) 110-128
42. Wosinska M. Direct-to-consumer advertising and drug therapy compliance. Journal of Marketing Research 42 3 (2005) 323-332
43. Yang, H. K., Mathios, A. D., & Avery, R. J. (2007, June). The impact of direct-to-consumer advertising of cholesterol reducing drugs on diagnosis and treatment of cholesterol. Working Paper, Department of Policy Analysis and Management, Cornell University.